Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Psyence Biomedical Ltd (PBM)

Psyence Biomedical Ltd (PBM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Psyence Biomed's Stake in PsyLabs Valued at $2 Million; Company Strengthens Financial Position and Advances Clinical Trials Quiver Quantitative, Inc. - Tue Dec 3, 4:48PM CST

Psyence Biomed reports $2 million stake in PsyLabs, reduces debt, and progresses Phase IIb clinical trial as Nasdaq compliance plan advances.Quiver AI SummaryPsyence Biomedical Ltd. announced significant...

PBM : 2.66 (+5.56%)
Psyence Biomedical Issues Shareholder Update Highlighting Recent Progress GlobeNewswire - Tue Dec 3, 6:30AM CST

PBM : 2.66 (+5.56%)
Psyence Biomedical Announces Favorable Result of Nasdaq Listing Qualifications Hearing GlobeNewswire - Wed Nov 20, 6:30AM CST

PBM : 2.66 (+5.56%)
Psyence Biomedical Ltd. Announces Share Consolidation Effective November 26, 2024 Quiver Quantitative, Inc. - Wed Nov 20, 1:20AM CST

Psyence Biomedical Ltd. announced a 1-for-75 share consolidation effective November 26 to comply with Nasdaq listing requirements.Quiver AI SummaryPsyence Biomedical Ltd. announced the effective date of...

PBM : 2.66 (+5.56%)
Psyence Biomedical Announces Effective Date for 1-for-75 Share Consolidation GlobeNewswire - Tue Nov 19, 3:05PM CST

PBM : 2.66 (+5.56%)
Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from Nasdaq GlobeNewswire - Tue Nov 12, 3:30PM CST

PBM : 2.66 (+5.56%)
Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group’s Stake in PsyLabs GlobeNewswire - Thu Oct 31, 6:30AM CDT

PBM : 2.66 (+5.56%)
Psyence Biomed Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care GlobeNewswire - Thu Oct 24, 6:00AM CDT

PBM : 2.66 (+5.56%)
Psyence Biomed Provides Progress Update on PsyLabs E.U. Good Manufacturing Practices (GMP) Certified Active Pharmaceutical Ingredient (API) Development GlobeNewswire - Thu Oct 17, 6:00AM CDT

PBM : 2.66 (+5.56%)
Psyence Biomed Provides Update on Previously Announced Acquisition of Clairvoyant GlobeNewswire - Fri Oct 4, 3:05PM CDT

PBM : 2.66 (+5.56%)

Barchart Exclusives

Is This Beaten-Down Penny Stock a Buy Post Q3 Earnings? Barchart - 15 minutes ago
ChargePoint’s Q3 financial results offered a glimmer of hope. Although revenue dropped 10% year-over-year, it exceeded Wall Street expectations. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot